Antiviral Research, volume 92, issue 3, pages 389-407
Nanobodies®: New ammunition to battle viruses
Peter Vanlandschoot
1
,
Catelijne STORTELERS
1
,
Els Beirnaert
1
,
Lorena Itatí Ibañez
2
,
B. Schepens
2
,
Erik Depla
1
,
1
Ablynx NV, Technologiepark 21, B-9052 Ghent, Belgium
|
Publication type: Journal Article
Publication date: 2011-12-01
Journal:
Antiviral Research
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor: 7.6
ISSN: 01663542, 18729096
Pharmacology
Virology
Abstract
► Heavy chain-only antibodies discovered in Camelidae . ► Biophysical and biochemical features of Nanobodies. ► Pre-clinical anti-viral therapeutic applications of Nanobodies. In 1989, a new type of antibody was identified, first in the sera of dromedaries and later also in all other species of the Camelidae family. These antibodies do not contain a light chain and also lack the first constant heavy domain. Today it is still unclear what the evolutionary advantage of such heavy chain-only antibodies could be. In sharp contrast, the broad applicability of the isolated variable antigen-binding domains (VHH) was rapidly recognized, especially for the development of therapeutic proteins, called Nanobodies®. Here we summarize first some of the unique characteristics and features of VHHs. These will next be described in the context of different experimental therapeutic applications of Nanobodies against different viruses: HIV, Hepatitis B virus, influenza virus, Respiratory Syncytial virus, Rabies virus, FMDV, Poliovirus, Rotavirus, and PERVs. Next, the diagnostic application of VHHs (Vaccinia virus, Marburg virus and plant Tulip virus X), as well as an industrial application (lytic lactococcal 936 phage) will be described. In addition, the described data show that monovalent Nanobodies can possess unique characteristics not observed with conventional antibodies. The straightforward formatting into bivalent, multivalent, and/or multispecific Nanobodies allowed tailoring molecules for potency and cross-reactivity against viral targets with high sequence diversity.
Top-30
Citations by journals
|
1
2
3
4
5
6
|
|
|
Frontiers in Immunology
6 publications, 5.04%
|
|
|
PLoS ONE
5 publications, 4.2%
|
|
|
Journal of Virology
5 publications, 4.2%
|
|
|
Scientific Reports
3 publications, 2.52%
|
|
|
PLoS Pathogens
3 publications, 2.52%
|
|
|
Viruses
2 publications, 1.68%
|
|
|
Vaccines
2 publications, 1.68%
|
|
|
Biomolecules
2 publications, 1.68%
|
|
|
Frontiers in Microbiology
2 publications, 1.68%
|
|
|
Plant Molecular Biology
2 publications, 1.68%
|
|
|
Molecular Immunology
2 publications, 1.68%
|
|
|
Antiviral Research
2 publications, 1.68%
|
|
|
ACS applied materials & interfaces
2 publications, 1.68%
|
|
|
Antimicrobial Agents and Chemotherapy
2 publications, 1.68%
|
|
|
Future Virology
1 publication, 0.84%
|
|
|
Hepatology
1 publication, 0.84%
|
|
|
Therapeutic Delivery
1 publication, 0.84%
|
|
|
ATLA Alternatives to Laboratory Animals
1 publication, 0.84%
|
|
|
International Journal of Molecular Sciences
1 publication, 0.84%
|
|
|
Diagnostics
1 publication, 0.84%
|
|
|
Antibodies
1 publication, 0.84%
|
|
|
Frontiers in Nuclear Medicine
1 publication, 0.84%
|
|
|
Nature Nanotechnology
1 publication, 0.84%
|
|
|
BMC Veterinary Research
1 publication, 0.84%
|
|
|
Molecular Imaging and Biology
1 publication, 0.84%
|
|
|
Plant Methods
1 publication, 0.84%
|
|
|
Retrovirology
1 publication, 0.84%
|
|
|
Nature Methods
1 publication, 0.84%
|
|
|
Journal of Nanobiotechnology
1 publication, 0.84%
|
|
|
1
2
3
4
5
6
|
Citations by publishers
|
5
10
15
20
25
|
|
|
Elsevier
21 publications, 17.65%
|
|
|
Springer Nature
16 publications, 13.45%
|
|
|
Multidisciplinary Digital Publishing Institute (MDPI)
10 publications, 8.4%
|
|
|
Frontiers Media S.A.
9 publications, 7.56%
|
|
|
Wiley
8 publications, 6.72%
|
|
|
Public Library of Science (PLoS)
8 publications, 6.72%
|
|
|
American Society for Microbiology
8 publications, 6.72%
|
|
|
Taylor & Francis
5 publications, 4.2%
|
|
|
American Chemical Society (ACS)
4 publications, 3.36%
|
|
|
Cold Spring Harbor Laboratory
4 publications, 3.36%
|
|
|
Future Medicine
2 publications, 1.68%
|
|
|
SAGE
2 publications, 1.68%
|
|
|
American Association for the Advancement of Science (AAAS)
2 publications, 1.68%
|
|
|
American Society for Biochemistry and Molecular Biology
1 publication, 0.84%
|
|
|
KeAi Communications Co.
1 publication, 0.84%
|
|
|
Czech Academy of Agricultural Sciences
1 publication, 0.84%
|
|
|
Dove Medical Press
1 publication, 0.84%
|
|
|
IEEE
1 publication, 0.84%
|
|
|
Central Research Institute for Epidemiology
1 publication, 0.84%
|
|
|
Proceedings of the National Academy of Sciences (PNAS)
1 publication, 0.84%
|
|
|
Rockefeller University Press
1 publication, 0.84%
|
|
|
Annual Reviews
1 publication, 0.84%
|
|
|
Royal Society of Chemistry (RSC)
1 publication, 0.84%
|
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 0.84%
|
|
|
5
10
15
20
25
|
- We do not take into account publications without a DOI.
- Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
- Statistics recalculated weekly.
{"yearsCitations":{"type":"bar","data":{"show":true,"labels":[2012,2013,2014,2015,2016,2017,2018,2019,2020,2021,2022,2023,2024],"ids":[0,0,0,0,0,0,0,0,0,0,0,0,0],"codes":[0,0,0,0,0,0,0,0,0,0,0,0,0],"imageUrls":["","","","","","","","","","","","",""],"datasets":[{"label":"Citations number","data":[6,16,10,13,7,7,6,8,9,10,12,6,9],"backgroundColor":["#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6"],"percentage":["5.04","13.45","8.4","10.92","5.88","5.88","5.04","6.72","7.56","8.4","10.08","5.04","7.56"],"barThickness":null}]},"options":{"indexAxis":"x","maintainAspectRatio":true,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"},"stacked":false},"x":{"ticks":{"stepSize":1,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"},"stacked":false}},"plugins":{"legend":{"position":"top","labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"Citations per year","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}},"journals":{"type":"bar","data":{"show":true,"labels":["Frontiers in Immunology","PLoS ONE","Journal of Virology","Scientific Reports","PLoS Pathogens","Viruses","Vaccines","Biomolecules","Frontiers in Microbiology","Plant Molecular Biology","Molecular Immunology","Antiviral Research","ACS applied materials & interfaces","Antimicrobial Agents and Chemotherapy","Future Virology","Hepatology","Therapeutic Delivery","ATLA Alternatives to Laboratory Animals","International Journal of Molecular Sciences","Diagnostics","Antibodies","Frontiers in Nuclear Medicine","Nature Nanotechnology","BMC Veterinary Research","Molecular Imaging and Biology","Plant Methods","Retrovirology","Nature Methods","Journal of Nanobiotechnology"],"ids":[1699,24963,19580,13767,5093,2455,24868,13780,24403,18646,24310,22274,1458,17567,7862,6346,12221,11467,14627,18499,25824,29101,337,17612,8168,14396,16436,14446,11794],"codes":[0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0],"imageUrls":["\/storage\/images\/resized\/4QWA67eqfcfyOiA8Wk7YnqroHFqQbTsmDJUYTCTg_medium.webp","\/storage\/images\/resized\/PRGhlgB4OKRltSNtT39eA6wlnOTGRap1QQ6FQHih_medium.webp","\/storage\/images\/resized\/VPE7q24PXoHr5SS2SqfEgxccSMUxWLfZINOX60uo_medium.webp","\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp","\/storage\/images\/resized\/PRGhlgB4OKRltSNtT39eA6wlnOTGRap1QQ6FQHih_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/4QWA67eqfcfyOiA8Wk7YnqroHFqQbTsmDJUYTCTg_medium.webp","\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/iLiQsFqFaSEx6chlGQ5fbAwF6VYU3WWa08hkss0g_medium.webp","\/storage\/images\/resized\/VPE7q24PXoHr5SS2SqfEgxccSMUxWLfZINOX60uo_medium.webp","\/storage\/images\/resized\/AN2jnDN59NmKaS4CWLHAGstADL2DbnatQScsFA6C_medium.webp","\/storage\/images\/resized\/bRyGpdm98BkAUYiK1YFNpl5Z7hPu6Gd87gbIeuG3_medium.webp","\/storage\/images\/resized\/AN2jnDN59NmKaS4CWLHAGstADL2DbnatQScsFA6C_medium.webp","\/storage\/images\/resized\/ruydfaB80LDjlkYqsfOeUAZohOIODyq7bQzis5O7_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/4QWA67eqfcfyOiA8Wk7YnqroHFqQbTsmDJUYTCTg_medium.webp","\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp","\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp","\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp","\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp","\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp","\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp","\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp"],"datasets":[{"label":"","data":[6,5,5,3,3,2,2,2,2,2,2,2,2,2,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1],"backgroundColor":["#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6"],"percentage":[5.04,4.2,4.2,2.52,2.52,1.68,1.68,1.68,1.68,1.68,1.68,1.68,1.68,1.68,0.84,0.84,0.84,0.84,0.84,0.84,0.84,0.84,0.84,0.84,0.84,0.84,0.84,0.84,0.84],"barThickness":13}]},"options":{"indexAxis":"y","maintainAspectRatio":false,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"},"stacked":false},"x":{"ticks":{"stepSize":null,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"},"stacked":false}},"plugins":{"legend":{"position":"top","labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"Journals","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}},"publishers":{"type":"bar","data":{"show":true,"labels":["Elsevier","Springer Nature","Multidisciplinary Digital Publishing Institute (MDPI)","Frontiers Media S.A.","Wiley","Public Library of Science (PLoS)","American Society for Microbiology","Taylor & Francis","American Chemical Society (ACS)","Cold Spring Harbor Laboratory","Future Medicine","SAGE","American Association for the Advancement of Science (AAAS)","American Society for Biochemistry and Molecular Biology","KeAi Communications Co.","Czech Academy of Agricultural Sciences","Dove Medical Press","IEEE","Central Research Institute for Epidemiology","Proceedings of the National Academy of Sciences (PNAS)","Rockefeller University Press","Annual Reviews","Royal Society of Chemistry (RSC)","Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii"],"ids":[17,8,202,208,11,344,142,18,40,6909,6949,31,189,2090,326,173,417,6953,7217,162,22,6941,123,9422],"codes":[0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0],"imageUrls":["\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/4QWA67eqfcfyOiA8Wk7YnqroHFqQbTsmDJUYTCTg_medium.webp","\/storage\/images\/resized\/bRyGpdm98BkAUYiK1YFNpl5Z7hPu6Gd87gbIeuG3_medium.webp","\/storage\/images\/resized\/PRGhlgB4OKRltSNtT39eA6wlnOTGRap1QQ6FQHih_medium.webp","\/storage\/images\/resized\/VPE7q24PXoHr5SS2SqfEgxccSMUxWLfZINOX60uo_medium.webp","\/storage\/images\/resized\/5YZtvLvkPZuc2JHOaZsjCvGSHFCuC3drUwN3YAc5_medium.webp","\/storage\/images\/resized\/iLiQsFqFaSEx6chlGQ5fbAwF6VYU3WWa08hkss0g_medium.webp","\/storage\/images\/resized\/hg4jJjT8wVGtHstBCc0zk465Mg9pLx3G4odCDOqE_medium.webp","\/storage\/images\/resized\/AN2jnDN59NmKaS4CWLHAGstADL2DbnatQScsFA6C_medium.webp","\/storage\/images\/resized\/ruydfaB80LDjlkYqsfOeUAZohOIODyq7bQzis5O7_medium.webp","\/storage\/images\/resized\/s10mcsCV4OAUg9O2KrqOquQC0PhyLMI8hUUkuflM_medium.webp","\/storage\/images\/resized\/OuA6WPZekwEiUM99mP2pSqj4yHPxHezM6xgLhAjO_medium.webp","\/storage\/images\/resized\/jeWDR7NTA9Ab5MVz8Uqjl2RPCndzFjSyl0FaRAHg_medium.webp","","\/storage\/images\/resized\/wVWp6zaxUsMdR03dYMdOZoesUrVGtNMWkHKByIvT_medium.webp","\/storage\/images\/resized\/6scCJegesojp2jubwY3uKCzTAmgsaH2GIFlg6Hfk_medium.webp","\/storage\/images\/resized\/HxgFXojL9GSWD86Qe827ZjqG8ciNkkviz42FIGJU_medium.webp","\/storage\/images\/resized\/mxFdPe9qujsfvfYfcN0QOclAiYORFb0xrRlwV8gs_medium.webp","\/storage\/images\/resized\/lEA1FyUnFAZR1DchuczZi5bjAixG3TNeWVz6oF4R_medium.webp","\/storage\/images\/resized\/A7oGMwx1m3fFJlKJvQUVra8h0itmEa7JZW0q3Q0b_medium.webp","\/storage\/images\/resized\/leiAYcRDGTSl5B1eCnwpSGqmDEUEfDPPoYisFGhT_medium.webp","\/storage\/images\/resized\/9Mus3KG1Tkd7Bwaurt8H3RwWh0CxRlGoO6ng9UK1_medium.webp"],"datasets":[{"label":"","data":[21,16,10,9,8,8,8,5,4,4,2,2,2,1,1,1,1,1,1,1,1,1,1,1],"backgroundColor":["#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6"],"percentage":[17.65,13.45,8.4,7.56,6.72,6.72,6.72,4.2,3.36,3.36,1.68,1.68,1.68,0.84,0.84,0.84,0.84,0.84,0.84,0.84,0.84,0.84,0.84,0.84],"barThickness":13}]},"options":{"indexAxis":"y","maintainAspectRatio":false,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"},"stacked":false},"x":{"ticks":{"stepSize":null,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"},"stacked":false}},"plugins":{"legend":{"position":"top","labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"Publishers","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}},"yearsCitationsQuartiles":{"type":"bar","data":{"show":true,"labels":[2012,2013,2014,2015,2016,2017,2018,2019,2020,2021,2022,2023,2024],"ids":[],"codes":[],"imageUrls":[],"datasets":[{"label":"Q4","backgroundColor":"rgb(221,90,78)","data":[0,0,0,0,0,0,0,1,1,0,0,0,0],"percentage":["0","0","0","0","0","0","0","0.84","0.84","0","0","0","0"]},{"label":"Q3","backgroundColor":"rgb(251, 163,83)","data":[1,0,0,0,0,1,2,0,0,1,0,0,0],"percentage":["0.84","0","0","0","0","0.84","1.68","0","0","0.84","0","0","0"]},{"label":"Q2","backgroundColor":"rgb(232, 213, 89)","data":[0,2,3,1,1,2,0,0,1,2,1,1,0],"percentage":["0","1.68","2.52","0.84","0.84","1.68","0","0","0.84","1.68","0.84","0.84","0"]},{"label":"Q1","backgroundColor":"rgb(164, 207, 99)","data":[4,12,6,9,6,4,3,4,6,5,10,2,8],"percentage":["3.36","10.08","5.04","7.56","5.04","3.36","2.52","3.36","5.04","4.2","8.4","1.68","6.72"]},{"label":"Quartile not defined","backgroundColor":"#E5E7EB","data":[1,2,1,3,0,0,1,3,1,2,1,3,1],"percentage":["0.84","1.68","0.84","2.52","0","0","0.84","2.52","0.84","1.68","0.84","2.52","0.84"]}]},"options":{"indexAxis":"x","maintainAspectRatio":true,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"},"stacked":true},"x":{"ticks":{"stepSize":1,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"},"stacked":true}},"plugins":{"legend":{"position":"top","labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"Citations quartiles by SCImago per year","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}},"yearsCitationsQuartilesWs":{"type":"bar","data":{"show":true,"labels":[2012,2013,2014,2015,2016,2017,2018,2019,2020,2021,2022,2023,2024],"ids":[],"codes":[],"imageUrls":[],"datasets":[{"label":"Q4","backgroundColor":"rgb(221,90,78)","data":[0,0,0,0,0,1,1,0,0,0,0,0,0],"percentage":["0","0","0","0","0","0.84","0.84","0","0","0","0","0","0"]},{"label":"Q3","backgroundColor":"rgb(251, 163,83)","data":[1,0,1,1,0,1,0,0,2,2,0,1,0],"percentage":["0.84","0","0.84","0.84","0","0.84","0","0","1.68","1.68","0","0.84","0"]},{"label":"Q2","backgroundColor":"rgb(232, 213, 89)","data":[1,3,5,5,3,1,0,4,1,0,3,0,1],"percentage":["0.84","2.52","4.2","4.2","2.52","0.84","0","3.36","0.84","0","2.52","0","0.84"]},{"label":"Q1","backgroundColor":"rgb(164, 207, 99)","data":[3,9,3,4,4,4,2,0,5,5,8,2,7],"percentage":["2.52","7.56","2.52","3.36","3.36","3.36","1.68","0","4.2","4.2","6.72","1.68","5.88"]},{"label":"Quartile not defined","backgroundColor":"#E5E7EB","data":[1,4,1,3,0,0,3,4,1,3,1,3,1],"percentage":["0.84","3.36","0.84","2.52","0","0","2.52","3.36","0.84","2.52","0.84","2.52","0.84"]}]},"options":{"indexAxis":"x","maintainAspectRatio":true,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"},"stacked":true},"x":{"ticks":{"stepSize":1,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"},"stacked":true}},"plugins":{"legend":{"position":"top","labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"Citations quartiles by WoS per year","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}}}
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Vanlandschoot P. et al. Nanobodies®: New ammunition to battle viruses // Antiviral Research. 2011. Vol. 92. No. 3. pp. 389-407.
GOST all authors (up to 50)
Copy
Vanlandschoot P., STORTELERS C., Beirnaert E., Ibañez L. I., Schepens B., Depla E., Saelens X. Nanobodies®: New ammunition to battle viruses // Antiviral Research. 2011. Vol. 92. No. 3. pp. 389-407.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1016/j.antiviral.2011.09.002
UR - https://doi.org/10.1016/j.antiviral.2011.09.002
TI - Nanobodies®: New ammunition to battle viruses
T2 - Antiviral Research
AU - Vanlandschoot, Peter
AU - STORTELERS, Catelijne
AU - Beirnaert, Els
AU - Ibañez, Lorena Itatí
AU - Schepens, B.
AU - Depla, Erik
AU - Saelens, Xavier
PY - 2011
DA - 2011/12/01 00:00:00
PB - Elsevier
SP - 389-407
IS - 3
VL - 92
SN - 0166-3542
SN - 1872-9096
ER -
Cite this
BibTex
Copy
@article{2011_Vanlandschoot,
author = {Peter Vanlandschoot and Catelijne STORTELERS and Els Beirnaert and Lorena Itatí Ibañez and B. Schepens and Erik Depla and Xavier Saelens},
title = {Nanobodies®: New ammunition to battle viruses},
journal = {Antiviral Research},
year = {2011},
volume = {92},
publisher = {Elsevier},
month = {dec},
url = {https://doi.org/10.1016/j.antiviral.2011.09.002},
number = {3},
pages = {389--407},
doi = {10.1016/j.antiviral.2011.09.002}
}
Cite this
MLA
Copy
Vanlandschoot, Peter, et al. “Nanobodies®: New ammunition to battle viruses.” Antiviral Research, vol. 92, no. 3, Dec. 2011, pp. 389-407. https://doi.org/10.1016/j.antiviral.2011.09.002.